Clinical and Translational Allergy (Sep 2024)
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®
- Jean Bousquet,
- Bernardo Sousa‐Pinto,
- Josep M. Anto,
- Anna Bedbrook,
- Wienczyslawa Czarlewski,
- Ignacio J. Ansotegui,
- Karl‐C. Bergmann,
- Fulvio Braido,
- Luisa Brussino,
- Lorenzo Cecchi,
- Claudia Chaves Loureiro,
- Alvaro A. Cruz,
- Philippe Devillier,
- Alessandro Fiocchi,
- Bilun Gemicioglu,
- Tari Haahtela,
- Juan Carlos Ivancevich,
- Ludger Klimek,
- Marek Kulus,
- Piotr Kuna,
- Maciej Kupczyk,
- Violeta Kvedariene,
- Desiree E. Larenas‐Linnemann,
- Gilles Louis,
- Renaud Louis,
- Michael Makris,
- Mario Morais‐Almeida,
- Marek Niedoszytko,
- Ken Ohta,
- Markus Ollert,
- Nikolaos Papadopoulos,
- Vincenzo Patella,
- Benoit Pétré,
- Oliver Pfaar,
- Francesca Puggioni,
- Santiago Quirce,
- Frederico S. Regateiro,
- Nicolas Roche,
- Philip W. Rouadi,
- Boleslaw Samolinski,
- Joaquin Sastre,
- Florence Schleich,
- Nicola Scichilone,
- Luis Taborda‐Barata,
- Sanna Toppila‐Salmi,
- Arunas Valiulis,
- Ilgim Vardaloglu Koyuncu,
- Maria Teresa Ventura,
- Arzu Yorgancioglu,
- Joao A. Fonseca,
- Torsten Zuberbier
Affiliations
- Jean Bousquet
- Institute of Allergology Charité – Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany
- Bernardo Sousa‐Pinto
- MEDCIDS ‐ Department of Community Medicine Information and Health Decision Sciences Faculty of Medicine University of Porto Porto Portugal
- Josep M. Anto
- ISGlobal Barcelona Institute for Global Health Barcelona Spain
- Anna Bedbrook
- ARIA Montpellier France
- Wienczyslawa Czarlewski
- ARIA Montpellier France
- Ignacio J. Ansotegui
- Department of Allergy and Immunology Hospital Quironsalud Bizkaia Bilbao Spain
- Karl‐C. Bergmann
- Institute of Allergology Charité – Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany
- Fulvio Braido
- Respiratory and Allergy Clinic, IRCCS ‐ Policlinico San Martino and Department of Internal Medicine (DIMI), University of Genoa Genoa Italy
- Luisa Brussino
- Department of Medical Sciences University of Torino Torino Italy
- Lorenzo Cecchi
- SOS Allergology and Clinical Immunology USL Toscana Centro Prato Italy
- Claudia Chaves Loureiro
- Department of Pneumology and University of Coimbra Medicine Faculty Coimbra Portugal
- Alvaro A. Cruz
- Fundaçao ProAR Federal University of Bahia and GARD/WHO Planning Group Salvador Bahia Brazil
- Philippe Devillier
- VIM Suresnes UMR 0892 Pôle des Maladies des Voies Respiratoires Hôpital Foch Université Paris‐Saclay Suresnes France
- Alessandro Fiocchi
- Allergy Bambino Gesù Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Rome Italy
- Bilun Gemicioglu
- Department of Pulmonary Diseases and Institute of Pulmonology and Tuberculosis Istanbul University‐Cerrahpaşa Cerrahpaşa Faculty of Medicine Istanbul Turkey
- Tari Haahtela
- Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki Helsinki Finland
- Juan Carlos Ivancevich
- Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
- Ludger Klimek
- Department of Otolaryngology Head and Neck Surgery Universitätsmedizin Mainz Mainz Germany
- Marek Kulus
- Department of Pediatric Respiratory Diseases and Allergology Medical University of Warsaw Warsaw Poland
- Piotr Kuna
- Division of Internal Medicine Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
- Maciej Kupczyk
- Division of Internal Medicine Asthma and Allergy Barlicki University Hospital Medical University of Lodz Lodz Poland
- Violeta Kvedariene
- Institute of Clinical Medicine Clinic of Chest Diseases and Allergology Faculty of Medicine Vilnius University Vilnius Lithuania
- Desiree E. Larenas‐Linnemann
- Center of Excellence in Asthma and Allergy Médica Sur Clinical Foundation and Hospital México City Mexico
- Gilles Louis
- Department of Public Health University of Liège Liège Belgium
- Renaud Louis
- Department of Pulmonary Medicine CHU Liège Liège Belgium
- Michael Makris
- Allergy Unit “D Kalogeromitros” 2nd Department of Dermatology and Venereology National & Kapodistrian University of Athens “Attikon” University Hospital Athens Greece
- Mario Morais‐Almeida
- Allergy Center CUF Descobertas Hospital Lisbon Portugal
- Marek Niedoszytko
- Department of Allergology Medical University of Gdańsk Gdansk Poland
- Ken Ohta
- Japan Antituberculosis Association (JATA) Fukujuji Hospital Tokyo Japan
- Markus Ollert
- Department of Infection and Immunity Luxembourg Institute of Health Esch‐sur‐Alzette Luxembourg
- Nikolaos Papadopoulos
- Allergy Department 2nd Pediatric Clinic University of Athens Athens Greece
- Vincenzo Patella
- Division of Allergy and Clinical Immunology Department of Medicine “Santa Maria della Speranza” Hospital Salerno Italy
- Benoit Pétré
- Department of Public Health University of Liège Liège Belgium
- Oliver Pfaar
- Section of Rhinology and Allergy Department of Otorhinolaryngology Head and Neck Surgery University Hospital Marburg Philipps‐Universität Marburg Marburg Germany
- Francesca Puggioni
- IRCCS Humanitas Research Center Personalized Medicine Asthma & Allergy Milan Italy
- Santiago Quirce
- Department of Allergy Hospital La Paz Institute for Health Research (IdiPAZ) Madrid Spain
- Frederico S. Regateiro
- Allergy and Clinical Immunology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra Coimbra Portugal
- Nicolas Roche
- Pneumologie AP‐HP Centre Université de Paris Cité Hôpital Cochin Paris France
- Philip W. Rouadi
- Department of Otolaryngology‐Head and Neck Surgery Eye and Ear University Hospital Beirut Lebanon
- Boleslaw Samolinski
- Department of Prevention of Environmental Hazards Allergology and Immunology Medical University of Warsaw Warsaw Poland
- Joaquin Sastre
- Allergy Service Fundacion Jimenez Diaz Autonoma University of Madrid CIBERES‐ISCIII Madrid Spain
- Florence Schleich
- Department of Pulmonary Medicine CHU Liège Liège Belgium
- Nicola Scichilone
- PROMISE Department University of Palermo Palermo Italy
- Luis Taborda‐Barata
- Department of Immunoallergology Cova da Beira University Hospital Centre Covilhã Portugal
- Sanna Toppila‐Salmi
- Department of Otorhinolaryngology University of Eastern Finland and the North Savo Wellbeing Services County Kuopio Finland
- Arunas Valiulis
- Clinic of Asthma, Allergy, and Chronic Lung Diseases Vilnius Lithuania
- Ilgim Vardaloglu Koyuncu
- Department of Pulmonary Diseases and Institute of Pulmonology and Tuberculosis Istanbul University‐Cerrahpaşa Cerrahpaşa Faculty of Medicine Istanbul Turkey
- Maria Teresa Ventura
- University of Bari Medical School Bari Italy
- Arzu Yorgancioglu
- Department of Pulmonary Diseases Celal Bayar University Faculty of Medicine Manisa Turkey
- Joao A. Fonseca
- MEDCIDS ‐ Department of Community Medicine Information and Health Decision Sciences Faculty of Medicine University of Porto Porto Portugal
- Torsten Zuberbier
- Institute of Allergology Charité – Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany
- DOI
- https://doi.org/10.1002/clt2.12390
- Journal volume & issue
-
Vol. 14,
no. 9
pp. n/a – n/a
Abstract
Abstract Patient‐reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person‐centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK‐air® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut‐offs and responsiveness. Then, a multicentric, multinational, double‐blind, placebo‐controlled, randomised control trial (DB‐PC‐RCT) using an electronic VAS form was carried out. Finally, with the development of MASK‐air® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ‐5D are included in the app. Additionally, two control‐medication scores for allergic symptoms of asthma (e‐DASTHMA) were validated for their criterion validity, cut‐offs and responsiveness.
Keywords
